MedGenome is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, ophthalmology, and rare diseases. The company has a high-throughput Next-Generation Sequencing facility in Foster City, California, supporting biomarker identification and target discovery research projects for bio-pharma and academic institutions in the US, Europe and Canada. MedGenome is a market leader in genetic diagnostic testing in India and has created the largest known clinico-genomic datasets on South Asian populations. MedGenome has developed algorithms and tools to correlate genomic data with clinical and phenotypic information to provide deep insight into complex diseases at a genetic and molecular level to support drug development and personalized medicine programs.